retatrutide clinical trial results 2024 2025 press release A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity | European Journal of Pharmacology Efficacy and safety of retatrutide,

Semaglutide came off the shortage list a year ago, but some companies have continued to provide the drug to patients under exceptions for 'personalised' treatments under a framework known as Section 503A

Small Lumps or Firmness Some people notice small lumps, called nodules, or a thickening of the skin around the area where they inject their GLP-1

Ali Khan, A., Mudassir, J., Mohtar, N

The general safe peptides for women guide provides context for women navigating peptide use alongside GLP-1 therapy

While Semaglutide is more widely used for significant weight loss, Liraglutide may be better suited for certain individuals based on their health profile

Major health publications now routinely list creatine alongside protein and HMB as a reasonable add-on for people on GLP-1 medications who want to preserve muscle